1. Simultaneous positron emission tomography (PET) assessment of metabolism with 18F- fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study 
Pierre Vera, Pierre Bohn, Agathe Edet-Sanson, Alice Salles, Sebastien Hapdey, Isabelle Gardin, Jean-François Ménard, Romain Modzelewski, Luc Thiberville, Bernard Dubray 
Radiotherapy and Oncology 
Volume 98, Issue 1, Pages (January 2011)
DOI: /j.radonc
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

2. Fig. 1 Actual schedule for the five evaluable patients.
Radiotherapy and Oncology  , DOI: ( /j.radonc )
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

3. Fig. 2
SUVmax for FLT, FDG, and F-miso before and during radiotherapy (RT) for 4 tumours and 12 nodes. Symbols represent the mean SUVmax. Error bars are 2× the standard error of the mean (SEM).
Radiotherapy and Oncology  , DOI: ( /j.radonc )
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

4. Fig. 3 Correlations between the tracers’ uptakes.
Radiotherapy and Oncology  , DOI: ( /j.radonc )
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions

5. Fig. 4
Example of patient #003. Patient having 1 primary tumor and 4 mediastinal nodes [1 node is not presented at 46Gy (superimposition)].
Radiotherapy and Oncology  , DOI: ( /j.radonc )
Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions